HIV Cure Could Strip Benefits From Long-Term Survivors
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- HIV cure research has produced rare proof-of-concept cases showing durable control without ongoing antiretroviral therapy may be biologically possible, though current approaches are not yet scalable for most people living with HIV.
- The Ryan White HIV/AIDS Program served more than 600,000 people with HIV in 2024, representing over half of those diagnosed with HIV in the U.S., and is the central safety net the authors warn could be jeopardized.
- Roughly 300,000 long-term HIV survivors in the U.S. were diagnosed before effective antiretroviral therapy became widely available, and nearly half of all people living with HIV are now age 50 or older, according to the authors.
- Timothy Ray Brown, the first person documented cured of HIV, later faced housing difficulties — a cautionary example the authors cite to show biomedical milestones do not automatically translate into social or economic security.
- Under the Medicare end-stage renal disease policy, many patients lost coverage 36 months after a successful kidney transplant despite needing lifelong immunosuppressive drugs — a precedent the authors say illustrates the risk of tying benefits to a medical event rather than ongoing need.
- Ali Ahmed, Jeff Taylor, and Jeff Berry — affiliated with the Perelman School of Medicine, the HIV+Aging Research Project-Palm Springs, and The Reunion Project — urge federal and state agencies to issue guidance that cure or durable control must not automatically trigger loss of eligibility for Medicaid, Ryan White, or related programs.
Why it matters: For roughly 300,000 long-term U.S. survivors — and the 600,000-plus people the Ryan White program served in 2024 — a policy that ties benefits to HIV status rather than persistent need could strip housing, disability, and health coverage from aging patients the moment a cure or durable control is achieved, and the Medicare transplant precedent shows this risk is not hypothetical.
Ask SkimNews
